论文部分内容阅读
国际卒中试验 3ThirdInternationalStrokeTrial(IST 3) 背景 :每 10 0 0例在发病 6h内接受静脉rtPA治疗的急性卒中患者中有 5 5例患者可避免死亡或生活依赖。然而 ,目前在全世界范围内只有极少数患者接受rtPA治疗。国际卒中试验 3(IST 3)的目的是在提供哪类患者从静脉rtPA?
International Stroke Trial 3ThirdInternationalStrokeTrial (IST 3) Background: Fifty-five patients in every 100 cases of acute stroke who receive intravenous rtPA within 6 hours of onset of illness may be prevented from death or dependency. However, only a very small number of patients are currently treated with rtPA in the world. What is the purpose of the International Stroke Trial 3 (IST 3) in providing venous rtPA?